Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.71 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.71 |
| ▸ | CA1 | P00915 | 3/20 | 0.57 |
| ▸ | CA2 | P00918 | 3/20 | 0.57 |
| ▸ | CA9 | Q16790 | 3/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA3 | P07451 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
| ▸ | CA6 | P23280 | 1/20 | 0.57 |
| ▸ | CA5A | P35218 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.57 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.57 |
| ▸ | F11 | P03951 | 2/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | P4HB | P07237 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24608995 | 0.92 | LIPG (0.83) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL2707320 | 0.92 | LIPG (0.83) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL64653 | 0.90 | LPL (0.61) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL661288 | 0.88 | LPL (0.59) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL823021 | 0.88 | LIPG (0.59) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL171682 | 0.88 | LPL (0.59) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL16209769 | 0.88 | LIPG (0.59) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL16012911 | 0.88 | LIPG (0.59) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL3194727 | 0.88 | LIPG (0.59) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL3142593 | 0.88 | LPL (0.59) | LPLLIPGCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 563 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2551271-B1 | COPOLYMER CONTAINING FLUORENYLPORPHYRIN-BENZENE, PREPARATION METHOD AND USE THEREOF | OCEANS KING LIGHTING SCIENCE (CN) | 2014-08-27 | — | — | EP | claimed |
| US-8546512-B2 | Copolymer containing fluorenylporphyrin-benzene, preparation method and use thereof | OCEAN'S KING LIGHTING SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2013-10-01 | — | — | US | claimed |
| EP-2551271-A1 | COPOLYMER CONTAINING FLUORENYLPORPHYRIN-BENZENE, PREPARATION METHOD AND USE THEREOF | Ocean's King Lighting Science&Technology Co., Ltd. (CN) | 2013-01-30 | — | — | EP | claimed |
| US-20120329979-A1 | COPOLYMER CONTAINING FLUORENYLPORPHYRIN-BENZENE, PREPARATION METHOD AND USE THEREOF | OCEAN'S KING LIGHTING SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2012-12-27 | — | — | US | claimed |
| EP-4688750-A1 | SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF AS AMPK ACTIVATORS | Pfizer Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4051667-B1 | HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS | LILAC THERAPEUTICS INC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12480049-B2 | Compound and liquid crystal composition | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-11-25 | — | — | US | disclosed |
| US-20250109150-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2025-04-03 | — | — | US | disclosed |
| US-12268086-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2025-04-01 | — | — | US | disclosed |
| US-20250101018-A1 | HETEROARYL COMPOUNDS AND USES THEREOF | APRINOIA THERAPEUTICS LIMITED (CN) | 2025-03-27 | — | — | US | disclosed |
| US-20250066585-A1 | PHOTOINITIATORS, COMPOSITIONS, AND METHODS OF FORMING AN OBJECT | QUADRATIC 3D, INC. | 2025-02-27 | — | — | US | disclosed |
| US-20250064787-A1 | Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors | LILAC THERAPEUTICS INC (US) | 2025-02-27 | — | — | US | disclosed |
| US-20040062930-A1 | Electroactive polymers | 3M INNOVATIVE PROPERTIES COMPANY | 2004-04-01 | — | — | US | disclosed |
| US-6680401-B1 | BORON COMPOUNDS SUCH AS 4-(METHOXYMETHYL)-1,3,2-DIOXABOROLANE, USED AS COUPLERS OR CHEMICAL INTERMEDIATES FOR DRUGS, PESTICIDES OR IN COMBINATORIAL CHEMISTRY | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-01-20 | — | — | US | disclosed |
| WO-2003105237-A1 | SYNTHESIS OF PERYLENE-PORPHYRIN BUILDING BLOCKS AND POLYMERS THEREOF FOR THE PRODUCTION OF LIGHT-HARVESTING ARRAYS | NORTH CAROLINA STATE UNIVERSITY (US) | 2003-12-18 | — | — | WO | disclosed |
| US-20030109380-A1 | Catalytic boronate ester synthesis from boron reagents and hydrocarbons | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2003-06-12 | — | — | US | disclosed |
| US-20030075216-A1 | Synthesis of perylene-porphyrin building blocks and polymers thereof for the production of light-harvesting arrays | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-04-24 | — | — | US | disclosed |
| EP-1127060-A4 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2002-08-21 | — | — | EP | disclosed |
| EP-1127060-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000027853-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12268086-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, LEF1 | LPL 2598/4885LIPG 1295/4885CA1 870/4885 |
| US-20250101018-A1 | HETEROARYL COMPOUNDS AND USES THEREOF | MAPT, APP, SLCO1B3 | LPL 2599/4885LIPG 3662/4885CA1 398/4885 |
| US-20250109150-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | ORC3, OXER1, OR10J3 | LPL 3459/4885LIPG 4576/4885CA1 2413/4885 |
| US-20030109380-A1 | Catalytic boronate ester synthesis from boron reagents and hydrocarbons | HBB, BTD, HMBS | LPL 2647/4885LIPG 2509/4885CA1 1124/4885 |
| US-20250064787-A1 | Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors | GLS, DUOX1, HAO1 | LPL 1856/4885LIPG 1139/4885CA1 205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.